Possible ergotamine-caffeine-associated delirium.
An elderly patient with a history of chronic migraine was hospitalized with systolic hypertension and significant mental status changes, including increasing confusion, combative behavior, and remarkably detailed auditory hallucinations of several weeks' duration. Daily increased consumption of a product containing ergotamine 1 mg and caffeine 100 mg coincided with both onset and increasing severity of symptoms. To our knowledge, this is the first case reported in the contemporary literature of severe mental status changes and hallucination possibly due to ergotamine-caffeine.
Gulbranson
Scott H
SH
Good Samaritan Regional Medical Center, Phoenix, Arizona 85006, USA. scottgulbranson@hotmail.com
Mock
Roy E
RE
Wolfrey
Jeffrey D
JD
D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects* / Q000627:therapeutic use; D002110:Caffeine / Q000009:adverse effects* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D003693:Delirium / Q000139:chemically induced*; D004338:Drug Combinations; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy
D018712:Analgesics, Non-Narcotic; D000697:Central Nervous System Stimulants; D004338:Drug Combinations; D002110:Caffeine; D004878:Ergotamine